… , he held leadership roles at Shire, Adolor, Novartis, and Bayer. Mr … Harrow’s acquisition of Melt Pharmaceuticals, Harrow has completed the operational …

Here's a reality check that surprises many first-time biopharma CEOs: roughly half of newly approved products miss their first-year revenue forecasts.1 For those with scientific backgrounds, this can be especially jarring. If the FDA approves your …

Uniting NSW.ACT has received approval for a major redevelopment project at its Waverley Estate in Sydney’s eastern suburbs. The not-for-profit has set aside $500 million for the project, with plans to transform the 3.4-hectare site into an integrated …

… became CEO of Takeda Pharmaceuticals in 2015, one Japanese … the $62 billion acquisition of Shire, completed in 2019, which … Takeda’s acquisition of Shire Pharmaceuticals created more revenue growth than … that direction, and then Shire was an accelerator. It …

Blood Plasma Derivatives Market is estimated to valued USD 52.96 Bn in 2025 and expected to reach USD 98.69 Bn by 2032, growing CAGR of 9.3% from 2025 to 2032 BURLINGAME, CA, UNITED STATES, September 15, 2025 /⁨EINPresswire.com⁩/ -- Coherent …

What should someone consider before choosing eyelid surgery? CHATTANOOGA, TN, UNITED STATES, August 11, 2025 /⁨EINPresswire.com⁩/ -- What should someone consider before choosing eyelid surgery? In a feature article for HelloNation, facial plastic …

… Chief Executive Officer of Tonix Pharmaceuticals. “Having successfully built Tonix … acquisitions from companies such as Shire, Roche, Novartis and Sanofi. … Investor Contact Jessica Morris Tonix Pharmaceuticals investor.relations@tonixpharma.com (862 …

… Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer … by his co-founding of Shire Pharmaceuticals. He brings a wealth of …

… stage cystic fibrosis company; PMV Pharmaceuticals, Inc., a precision oncology company … , Inc., Mirati Therapeutics, Inc., Arena Pharmaceuticals, Inc., and Halozyme Therapeutics, Inc … held senior management roles at Shire Plc and Amgen, Inc., and …

… with rare genetic disorders at Shire Pharmaceuticals. He also worked closely with … companies and technologies to build Shire’s pipeline. Dr. Tzianabos is …